GAST and acute pancreatitis: Furthermore, the results suggest that cannabinoid HU210, the CB1/2 receptor agonist, has the therapeutic potential for AGML in acute pancreatitis by attenuating inflammation and restoring gastrin/somatostatin equilibrium, and then decreasing the secretion of gastric acid and pepsin.